78 filings
8-K
AVRO
AvroBio Inc
30 Jan 24
Regulation FD Disclosure
4:05pm
8-K
AVRO
AvroBio Inc
30 Jan 24
AVROBIO and Tectonic Therapeutic Announce Merger
8:39am
8-K
AVRO
AvroBio Inc
12 Jul 23
AVROBIO to Explore Strategic Alternatives
7:13am
8-K/A
AVRO
AvroBio Inc
14 Jun 23
Cost Associated with Exit or Disposal Activities
5:19pm
8-K
AVRO
AvroBio Inc
13 Jun 23
Other Events
4:41pm
8-K
0diyw3e gmw
12 Jun 23
Termination of a Material Definitive Agreement
7:19am
8-K
c8iamrreq8tj2pyfc
9 Jun 23
Departure of Directors or Certain Officers
4:11pm
8-K
5lbtt
22 May 23
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
7:04am
8-K
65yzksiyj6fabso2cyd
18 May 23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
7:11am
8-K
cdjqo0mp2xcwa2tq2r
11 May 23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
7:20am
8-K
ikdk1o
1 May 23
AVROBIO Announces Leadership Transition
7:40am
8-K
a3cf6
23 Mar 23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
7:11am
8-K
9l44r3
27 Feb 23
Other Events
4:39pm
8-K
k95ai0959pxn0k2k36r
7 Dec 22
Regulation FD Disclosure
7:37am
8-K
h2d1l2qlsdlrjozrbgw
8 Nov 22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
7:15am
8-K
oi3tf e5aq2d8fla81
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
ftuiua
9 Aug 22
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update
7:11am
8-K
qwv tudkaf12mt8ow8
29 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
t8c2uio13wgu 3z3v92
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
xzaq29
24 May 22
Regulation FD Disclosure
7:00am